Clinical trial NCT03584425: Imaging Laterality in Chronic Stroke Patients
Official title: Investigating the Neurobiologic Basis for Loss of Cortical Laterality in Chronic Stroke Patients
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: EARLY_PHASE1
Conditions: Stroke
Motor Cortex; Lesion
Keywords: BOLD Signal
Functional Magnetic Resonance Imaging
MR Spectroscopy
Anatomical Imaging
Kinematics
Lead sponsor: Medical University of South Carolina
Sponsor class: OTHER
Collaborators: name: MUSC Center for Biomedical Research Excellence in Stroke Recovery
First posted: 2018-07-12
Enrollment: 44
Sex: ALL
Minimum age (years): 21
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: NON_RANDOMIZED
Intervention model: PARALLEL
Intervention model description: The investigators will enroll a total of 30 chronic stroke patients and 30 neurologically healthy controls matched for age and with at least 2 cardiovascular risk factors
Primary purpose: DIAGNOSTIC

Brief summary: In healthy individuals, unimanual movement (with either the left or right hand) is associated with activity in a network of predominantly contralateral brain regions, including the primary motor cortex (PMC). This laterality is often compromised following a middle cerebral artery (MCA) stroke. Neuroimaging studies of these patients have shown that unimanual movements with the effected hand are associated with elevated Blood Oxygen-Level Dependent (BOLD) signal in both the lesioned and the nonlesioned primary motor cortices. Elevated activity in the contralesional PMC is well-established in chronic stroke patients and is associated with poor motor rehabilitation outcomes. Yet the neurobiologic basis for this aberrant neural activity is equivocal. The overarching goal of this project is to determine the neurobiologic basis for elevated activity in the contralesional primary motor cortex.

Detailed description: One factor that may contribute to elevated activity in the contralesional PMC is increased cortical excitatory tone within the contralesional hemisphere (Aim 1).

While approximately 80% of the descending corticospinal neurons that control the right hand originate in the left PMC, 20% originate in the right PMC. Elevated activity in the right PMC of left-sided stroke patients may reflect compensatory activity of these descending fibers. Neural activity in the PMC reflects the balance of local excitatory (glutamatergic) and inhibitory (GABAergic) processing. It can be measured in two manners: 1) electrophysiologically, using single hemisphere paired pulse transcranial magnetic stimulation (TMS), and 2) neurochemically, using magnetic resonance spectroscopy (MRS).

Another factor that may contribute to elevated activity in the contralesional PMC is a loss of transcallosal inhibition between the hemispheres (Aim 2). During right hand movement, the left PMC of healthy individuals actively inhibits the right PMC via inhibitory projections through the corpus callosum. In left MCA stroke patients, elevated activity in the contralesional (right) PMC when moving the right hand may reflect a loss of typical inhibition from the left PMC. The integrity of inter-hemispheric information transfer can be measured in two manners: 1) using bi-hemispheric paired-pulse TMS, and 2) using a multimodal brain stimulation/brain imaging approach, interleaved TMS/MRI.

Through interleaved TMS/MRI, the investigators can selectively stimulate the ipsilesional PMC and quantify the amount of TMS-induced activity in the contralesional PMC. These two explanations will be tested through a cross-sectional investigation of neural function in left MCA stroke patients with mild-moderate right upper extremity impairment and controls matched for age and cardiovascular risk factors. To assess the clinical relevance of these factors on motor dysfunction, the investigators will perform a detailed kinematic assessment of movement efficiency, smoothness and compensation (Aim 3).

Eligibility criteria: Inclusion Criteria For Both Groups:

* 21-80 years old of any race and ethnicity
* At least 2 cardiovascular risk factors (smoking, high blood pressure, high cholesterol, diabetes, overweight, age (\>55 for men, \>65 for women), family history of stroke).

Inclusion Criteria For Stroke Patients:

* Left middle cerebral artery ischemic stroke with at least 6 month chronicity
* Right upper extremity weakness with a Rasch-modified Fugl-Meyer upper extremity score of 20 to 50
* Ability to voluntarily flex the affected elbow and shoulder from 10-75% of the normal range
* Ability to make a fist and relax the affected hand (note: this motion will be required in the functional MRI task)

Exclusion Criteria For Both Groups:

* Primary intracerebral hematoma or subarachnoid hemorrhage
* Bi-hemispheric ischemic strokes
* History of prior right-sided stroke or old infarct demonstrated on the CT or MRI or documented in medical records
* Other concomitant neurological disorders affecting upper extremity motor function
* Documented history of dementia before or after stroke
* Presence of any MRI, TMS, or transcranial direct current stimulation risk factors such as an electrically, magnetically or mechanically activated metal or nonmetal implant including cardiac pacemaker, intracerebral vascular clips or any other electrically sensitive support system
* Pregnancy as the effect of MRI on the fetus is unknown, females of child bearing age must undergo a pregnancy test to confirm eligibility
* History of seizure disorder or post-stroke seizure
* Preexisting scalp lesion or wound or bone defect or hemicraniectomy
* Left-hand dominance (before the stroke in the stroke patients) as the typical pattern of laterality is not as strong in left-handed healthy individuals
* Current nicotine dependence (Note: nicotine use is not an exclusionary criteria as there is no known association between acute use and BOLD signal changes in non-dependent smokers)

Primary outcomes:
measure: Compare the ratio of gluatamte and gaba concentrations within the contralesional primary motor cortex
timeFrame: Through study completion, an average of two weeks
Secondary outcomes:
measure: Quantify the relationship between neural activity and motor performance using the Rasch modified version of the Fugl-Meyer motor assessment battery to acquire three aspects of motor performance for all individuals in both groups.
timeFrame: Through study completion, an average of two weeks
Other outcomes:
Locations:
city: Charleston
country: United States
facility: Medical University of South Carolina
state: South Carolina
Study officials:
affiliation: Medical University of South Carolina
name: Colleen A Hanlon, PhD
role: PRINCIPAL_INVESTIGATOR
References: